Skip to main content

Table 2 Cancer risk profiles in SLE and pSS patients

From: The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism

 

Systemic lupus erythematosus

Primary Sjogren’s syndrome

Increased risk

All hematologic cancers

(Including lymphoma, leukemia, multiple myeloma),

Lung cancer,

Liver and hepatobiliary cancer,

Vaginal and vulvar cancer,

Cervical dysplasia and precancerous lesions,

Thyroid cancer,

Head and neck cancer,

Renal cancer,

Nonmelanoma skin cancer

All hematologic cancers

(Including lymphoma, leukemia, multiple myeloma),

lung cancer,

Thyroid cancer

Lip and oropharyngeal cancer,

Liver cancer,

Nonmelanoma skin cancer

Inconsistent findings

Bladder cancer,

Cervical cancer,

Breast cancer,

Ovarian cancer

Breast cancer,

Bladder cancer,

Ovarian cancer,

Decreased risk

Prostate cancer,

Endometrial cancer,

Melanoma